USF-LVHN SELECT
Probing Interleukin-6 in Stroke Pathology and Neural Stem Cell Transplantation.
Publication/Presentation Date
12-7-2022
Abstract
Stem cell transplantation is historically understood as a powerful preclinical therapeutic following stroke models. Current clinical strategies including clot busting/retrieval are limited by their time windows (tissue plasminogen activator: 3-4 h) and inevitable reperfusion injuries. However, 24+ h post-stroke, stem cells reduce infarction size, improve neurobehavioral performance, and reduce inflammatory agents including interleukins. Typically, interleukin-6 (IL-6) is regarded as proinflammatory, and thus, preclinical studies often discuss it as beneficial for neurological recuperation when stem cells reduce IL-6's expression. However, some studies have also demonstrated neurological benefit with upregulation of IL-6 or preconditioning of stem cells with IL-6. This review specifically focuses on stem cells and IL-6, and their occasionally disparate, occasionally synergistic roles in the setting of ischemic cerebrovascular insults.
Volume
23
Issue
24
ISSN
1422-0067
Published In/Presented At
Lockard, G. M., Alayli, A., Monsour, M., Gordon, J., Schimmel, S., Elsayed, B., & Borlongan, C. V. (2022). Probing Interleukin-6 in Stroke Pathology and Neural Stem Cell Transplantation. International journal of molecular sciences, 23(24), 15453. https://doi.org/10.3390/ijms232415453
Disciplines
Medical Education | Medicine and Health Sciences
PubMedID
36555094
Department(s)
USF-LVHN SELECT Program, USF-LVHN SELECT Program Students
Document Type
Article